MILAN, Italy and PHILADELPHIA, Feb. 13, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies, announced today two appointments to its Research and Development and Medical Affairs management team. Dr. John Caminis, M.D., joins Eurand Pharmaceuticals, Inc. as Vice President, Medical Affairs and Clinical Development, and Dr. Marco Sardina, M.D., Ph.D., joins Eurand, S.p.A, as Director, Medical Affairs and Clinical Development, Europe.
